
Valponist 133.5mg/58mg Tablet CR
Marketer
Alienist Pharmaceutical Private Limited
Salt Composition
Sodium Valproate (133.5mg) + Valproic Acid (58mg)
Overview Valponist 133.5mg/58mg Tablet CR
Epilepsy, characterized by recurring seizures, can be managed with Valponist 133.5mg/58mg CR tablets, a dual-action medication. This formulation regulates aberrant brain activity, calming nerves to prevent seizure episodes. Administer Valponist with food; dosage is determined individually by your physician, potentially increasing gradually to optimize control. Therapeutic effects may take weeks, necessitating consistent use. Discontinuation, except under medical guidance, risks increased seizure frequency and potential exacerbation of bipolar symptoms if present. Common side effects include nausea and tremors; less frequent ones encompass vomiting, headache, hepatic impairment, and upper abdominal discomfort. Most side effects are transient, but persistent or bothersome symptoms warrant medical attention; mitigation strategies may be available. Prior to initiating Valponist, disclose any pre-existing kidney or liver disease, meningitis, depression, or suicidal ideation. Comprehensive medication disclosure is crucial, as interactions exist with other drugs, including contraceptives. While use during pregnancy or breastfeeding requires careful assessment and potential dosage modification, it remains a possibility if the benefits outweigh the risks. Avoid driving or cycling if drowsiness or dizziness occur. Regular blood tests monitor therapeutic response. Alcohol consumption should be avoided due to potential side effect intensification. Weight gain is a possibility; maintain a balanced diet, limit high-calorie snacks, and engage in regular physical activity. Report any unusual mood or behavioral shifts, worsening depression, or suicidal thoughts or actions immediately to your physician.
Primary Ingredients of Valponist 133.5mg/58mg Tablet CR
No text provided. Please provide the text you wish me to rephrase.
Uses of Valponist 133.5mg/58mg Tablet CR
Seizure disorder
Major Benefits of Valponist 133.5mg/58mg Tablet CR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Valponist 133.5mg/58mg Controlled-Release tablet should be administered with a meal.
Common Side effects of Valponist 133.5mg/58mg Tablet CR:
- Nausea
- Tremors
How to use Valponist 133.5mg/58mg Tablet CR:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the Valponist 133.5mg/58mg Controlled-Release tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
How Valponist 133.5mg/58mg Tablet CR works:
The extended-release tablet, Valponist CR, contains 133.5mg of sodium valproate and 58mg of valproic acid, a dual anticonvulsant formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Valponist 133.5mg/58mg CR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Valponist 133.5mg/58mg CR tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Valponist tablets (133.5mg/58mg) are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Taking Valponist 133.5mg/58mg CR tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can likely safely use Valponist 133.5mg/58mg Tablet CR. Preliminary findings indicate dose modification may be unnecessary, but a physician's consultation is advised. Individuals with pre-existing kidney conditions should discuss this medication with their doctor.
LiverCAUTION
Patients with liver impairment should use Valponist 133.5mg/58mg CR tablets cautiously, potentially requiring dosage modification. Consult your physician. Valponist 133.5mg/58mg CR tablets are contraindicated in patients with severe or active liver disease.
What if you forget to take Valponist 133.5mg/58mg Tablet CR :
Should you forget a Valponist 133.5mg/58mg CR tablet, take it immediately upon remembering. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Valponist 133.5mg/58mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
